(3).png){kind=avatar}
Copovidone is a high-performance pharmaceutical excipient belonging to the class of synthetic copolymers, widely used to address solubility and bioavailability challenges in modern drug development.
KoVidone VA64 is a premium commercial grade of copovidone, specifically engineered to meet stringent pharmaceutical standards and deliver consistent performance across advanced formulations.
In high-value formulations, especially those involving poorly water-soluble APIs copovidone plays a critical role in enhancing drug dispersion, stabilizing amorphous systems, and enabling scalable manufacturing.
Copovidone is a synthetic random copolymer composed of:
KoVidone VA64 is produced with a controlled VP/VA ratio (typically 6:4), resulting in a well-balanced amphiphilic polymer structure. This molecular architecture enables:
Its defined molecular weight distribution and low residual monomer content ensure compliance with major pharmacopeial standards (USP/NF, Ph. Eur.), making it highly suitable for regulated markets
.png)
KoVidone VA64 empowers pharmaceutical companies to minimize formulation risks while maximizing product consistency and scalability.
(1).png)
By integrating KoVidone VA64, manufacturers can significantly improve bioavailability, optimize therapeutic outcomes, and increase the commercial value of pharmaceutical products.
.png)
For more information about Copovidone sourcing, please contact us:
